Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: SW CRX) will today present an update on the Company’s strategy, research and development programs, product sales and financial outlook in a briefing to analysts and investors held at the Company’s Leiden headquarters. A live audio webcast of the briefing, featuring the presentation slides, can be accessed via the homepage of Crucell’s website at www.crucell.com, and will be archived and available for replay following the event.
